Ronald Asbury Andrews's Net Worth
-$38.4 Million
Who is Ronald Asbury Andrews?
Ronald Asbury Andrews does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Cardiac Science CORP, Precipio, Inc., Oncocyte Corp, Oxford Immunotec Global PLC, Life Technologies Corp, and CLARIENT, INC.
SEC CIK
Ronald Asbury Andrews's CIK is 0001299153
Past Insider Trading and Trends
2022 was Ronald Asbury Andrews's most active year for acquiring shares with 9 total transactions. Ronald Asbury Andrews's most active month to acquire stocks was the month of February. 2021 was Ronald Asbury Andrews's most active year for disposing of shares, totalling 12 transactions. Ronald Asbury Andrews's most active month to dispose stocks was the month of November. 2020 saw Ronald Asbury Andrews paying a total of $42,915,483.46 for 250,228 shares, this is the most they've acquired in one year. In 2010 Ronald Asbury Andrews cashed out on 581,500 shares for a total of $2,880,900.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Cardiac Science CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 4
| -100.00% | -1.00K |
$2.30 | -$2,300.00 |
0
|
Dec 1
| |||
Form 4
|
∞
| 1K |
—
|
—
| 1K |
Nov 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Precipio, Inc. (PRPO) Snapshot price: $6.9079
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
| +73.19% | 3.15K |
$6.66 | $20,998.98 | 7.46K |
Apr 15
| |||
Form 4
| +1,321.78% | 4K |
—
|
—
| 4.31K |
Oct 24
| |||
Form 4
|
∞
| 6.06K |
—
|
—
| 6.06K |
Sep 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Oncocyte Corp (OCX) Snapshot price: $2.9201
Former CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +75.03% | 250K |
—
|
—
| 583.21K |
Dec 1 - Dec 7
| |||
Form 4
| +13.64% | 40K |
$0.96 | $38,400.00 | 333.21K |
Aug 16
| |||
Form 4
| +20.56% | 50K |
$1.28 | $64,150.00 | 293.21K |
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
| +25.34% | 49.17K |
—
|
—
| 243.21K |
Jul 1
| |||
Form 4
| +70.67% | 80.35K |
—
|
—
| 194.05K |
May 7 - Jun 30
| |||
Form 4
| +10.71% | 11K |
$4.79 | $52,702.10 | 113.7K |
Mar 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
| +63.80% | 40K |
$1.35 | $53,880.00 | 102.7K |
Aug 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 4/A
| +258.64% | 45.22K |
$2.30 | $104,149.73 | 62.7K |
Mar 30 - Mar 31
| |||
Form 4
| +258.64% | 45.22K |
$945.63 | $42,757,453.73 | 62.7K |
Mar 30 - Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 30
| |||
Form 4
|
∞
| 17.48K |
—
|
—
| 17.48K |
Jul 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Oxford Immunotec Global PLC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.08K |
$22.00 | -$89,782.00 |
0
|
Mar 8
| |||
Form 4
|
∞
| 4.08K |
—
|
—
| 4.08K |
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Life Technologies Corp No price found
President, Medical Sciences
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -7.36K |
$76.13 | -$560,097.24 |
0
|
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
| +33.69% | 1.85K |
$65.75 | $121,900.50 | 7.36K |
Apr 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 29 - Apr 1
| |||
Form 4
| +65.26% | 2.17K |
$65.24 | $141,766.52 | 5.5K |
Feb 1
| |||
Form 4
|
∞
| 3.33K |
$46.49 | $154,814.03 | 3.33K |
Apr 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||